In summary, CTSB participated in AP through two pathways: one is to activate AP-1 via PKCα-JNK-cJun signaling and induce necroptosis, which is independent of trypsin activity; and the other way is to activate trypsinogen and induce necrosis. The gene discussed is JUN; the disease is alkaline phosphatase measurement.